NCT05971849View on ClinicalTrials.gov

Dampening the Reproductive Axis With Continuous Kisspeptin

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 6, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Reproductive DisorderPCOSPolycystic Ovary Syndrome
Interventions
DRUG

kisspeptin 112-121

IV infusion of kisspeptin 112-121 x 24 hours; up to two IV boluses of kisspeptin

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Stephanie B. Seminara, MD

OTHER